Articles

The Senate Must Streamline the Drug Regulatory Process (Wall Street Journal)


WALL STREET JOURNAL | Before the Senate is a powerful medical-innovation package of 19 bills—a companion to the House-approved 21st Century Cures Act—that will streamline the nation’s regulatory process for the discovery, development and delivery of safe and effective drugs and devices, bringing the process into the new century. This legislation, crafted by the Senate’s Health, Education, Labor and Pensions Committee, touches every American. Each of us has personal health battles or knows family members and friends who are fighting against devastating diseases. Passing this package will help ensure that patients’ perspectives are integrated into the drug-development and approval process and speed up the development of new antibiotics and treatments for those who need them most.

Read more at the Wall Street Journal (sub required)